Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Global Systemic Lupus Erythematous SLE Drug Market Growth 2024-2030
... growing demand in downstream market, the Systemic Lupus Erythematous SLE Drug is forecast to a readjusted size of US$ 265.8 million by 2030 with a CAGR of 4.9% during review period. The research report highlights ... Read More
-
Lupus Nephritis - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Lupus Nephritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Polyneuropathy Treatment Market Study by Diabetic, Chemotherapy-induced, Idiopathic, HIV/AIDS associated, and Autoimmune Polyneuropathy from 2024 to 2034
... a 10-year forecast for 2024 to 2034. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for ... Read More
-
Lupus Nephritis Treatment Market Report and Forecast 2024-2032
... driven by rising awareness about lupus nephritis. The market size is anticipated to grow at a CAGR of 7.5% during the forecast period of 2024-2032 to achieve a value of USD 3.4 billion by 2032. ... Read More
-
Saudi Arabia In-vitro Diagnostics Market Assessment, By Product Type [Instruments, Reagents and Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Hemostasis, Urinalysis, Others], By Settings [Laboratories, Point-of-Care], By Application [Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], Opportunities and Forecast, 2016-2030F
... Application [Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], Opportunities and Forecast, 2016-2030F Saudi Arabia in-vitro diagnostics market is projected ... Read More
-
Canada In-vitro Diagnostics Market Assessment, By Product [Instruments, Reagents and Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Hemostasis, Urinalysis, Others], By Settings [Laboratories, Point-of-care], By Application [Ophthalmology, Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Home Care Settings, Others], By End-users [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2017-2031F
... Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Home Care Settings, Others], By End-users [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2017-2031F Canada in-vitro diagnostics ... Read More
-
Global In-vitro Diagnostics Market Assessment, By Product Type [Instruments, Reagents and Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Hemostasis, Urinalysis, Others], By Settings [Laboratories, Point-of-Care], By Application [Infectious Diseases, Diabetes, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F
... [Infectious Diseases, Diabetes, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F Global In-vitro diagnostics market is projected to ... Read More
-
Biologics Market Assessment, By Product [Monoclonal Antibodies, Recombinant Hormones/Proteins, Vaccines, Cellular Based Biologics, Gene-Based Biologics, Therapeutic Enzymes, Others] By Application [Infectious Diseases, Cancer, Autoimmune Diseases, Cardiovascular, Hematological Disorders, Others] By Drug Classification [Branded Drugs, Generic Drugs], By Mode of Purchase [Prescription Drugs, Over-the-counter Drugs] By Distribution Channel [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies] By Region, Opportunities and Forecast, 2017-2031F
... Drugs], By Mode of Purchase [Prescription Drugs, Over-the-counter Drugs] By Distribution Channel [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies] By Region, Opportunities and Forecast, 2017-2031F Global biologics market size was valued at USD 401.34 billion in ... Read More
-
North America Bioanalytical Testing Services Market Forecast to 2030 - Regional Analysis - by Services (Pharmacokinetics, Biomarkers, Immunogenicity, Virology Testing, Cell-based assays, and Others); Disease Indication (Cardiovascular, Neurological Disorders, Metabolic Disorders, Autoimmune Disorders, Respiratory Diseases, Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others]
... Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others] The North America bioanalytical testing services market was valued ... Read More
-
Asia Pacific Bioanalytical Testing Services Market Forecast to 2030 - Regional Analysis - by Services (Pharmacokinetics, Biomarkers, Immunogenicity, Virology Testing, Cell-based assays, and Others); Disease Indication (Cardiovascular, Neurological Disorders, Metabolic Disorders, Autoimmune Disorders, Respiratory Diseases, Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others]
... Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others] The Asia Pacific bioanalytical testing services market was valued ... Read More
-
Middle East & Africa Bioanalytical Testing Services Market Forecast to 2030 - Regional Analysis - by Services (Pharmacokinetics, Biomarkers, Immunogenicity, Virology Testing, Cell-based assays, and Others); Disease Indication (Cardiovascular, Neurological Disorders, Metabolic Disorders, Autoimmune Disorders, Respiratory Diseases, Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others]
... Respiratory Diseases, Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others] The Middle East & Africa bioanalytical testing ... Read More
-
South & Central America Bioanalytical Testing Services Market Forecast to 2030 - Regional Analysis - by Services (Pharmacokinetics, Biomarkers, Immunogenicity, Virology Testing, Cell-based assays, and Others); Disease Indication (Cardiovascular, Neurological Disorders, Metabolic Disorders, Autoimmune Disorders, Respiratory Diseases, Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others]
... Respiratory Diseases, Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others] The South & Central America bioanalytical testing ... Read More
-
Europe Bioanalytical Testing Services Market Forecast to 2030 - Regional Analysis - by Services (Pharmacokinetics, Biomarkers, Immunogenicity, Virology Testing, Cell-based assays, and Others); Disease Indication (Cardiovascular, Neurological Disorders, Metabolic Disorders, Autoimmune Disorders, Respiratory Diseases, Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others]
... Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others] The Europe bioanalytical testing services market was valued at US$ ... Read More
-
Autoimmune Disease Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis
... according to Renub Research. Autoimmune diseases are diverse situations wherein the immune system mistakenly attacks the body's cells, tissues, and organs. These outcomes result in irritation and harm, causing various symptoms. Over 80 diagnosed autoimmune ... Read More
-
Middle East & Africa In-Vitro Diagnostics Market Forecast to 2030 – Regional Analysis – by Product & Services (Reagents & Kits, Instruments, and Software & Services), Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others)
... Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others) The Middle East & Africa in-vitro diagnostics ... Read More
-
Europe In-Vitro Diagnostics Market Forecast to 2030 – Regional Analysis – by Product & Services (Reagents & Kits, Instruments, and Software & Services), Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others)
... & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others) The Europe in-vitro diagnostics market is expected to grow from ... Read More
-
South & Central America In-Vitro Diagnostics Market Forecast to 2030 – Regional Analysis – by Product & Services (Reagents & Kits, Instruments, and Software & Services), Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others)
... Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others) The South & Central America in-vitro diagnostics ... Read More
-
Asia Pacific In-Vitro Diagnostics Market Forecast to 2030 – Regional Analysis – by Product & Services (Reagents & Kits, Instruments, and Software & Services), Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others)
... Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others) The Asia Pacific in-vitro diagnostics market is expected to ... Read More
-
Asia Pacific Next Generation Antibody Market, By Therapeutic Area (Oncology, Autoimmune/Inflammatory); By Technology (Antibody-Drug Conjugates (ADC's), Bispecific Antibodies, FC Engineered Antibodies, Antibody Fragments and Antibody-like Proteins, Biosimilar Antibody Products); By Country (China, India, Japan, South Korea, Indonesia, Vietnam, Malaysia, Rest of Asia Pacific), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... antibody research and development programs, advancements in biotechnology, and expanding healthcare infrastructure. BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Asia Pacific Next Generation Antibody Market size ... Read More
-
Global Lupus Nephritis Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... of the Lupus Nephritis industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Lupus Nephritis. The report also introduces players in the industry ... Read More
-
Immunotherapy Drugs Market (Drug Type: Monoclonal Antibodies, Immunomodulators, Cell Therapy and Others; and Therapy Area: Cancer, Autoimmune Diseases, Infectious Diseases, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Market – Scope of Report TMR’s report on the global immunotherapy drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
Bioengineered Protein Drugs Market by Drug Type (Monoclonal Antibodies, Therapeutic Proteins, Vaccines), Disease (Arthritis, Autoimmune Disorders, Blood Disorders), End-User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 415.13 billion in 2024, at a CAGR 7.76% to reach USD 653.35 billion by 2030. Global Bioengineered Protein Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Autoimmune Disease Diagnostics Market by Type (Localized Autoimmune Disease Diagnostics, Systemic Autoimmune Disease Diagnostics), Indication (Addison Disease, Celiac Disease, Dermatomyositis), Test, Product, End User - Global Forecast 2024-2030
... estimated at USD 5.08 billion in 2023 and expected to reach USD 5.53 billion in 2024, at a CAGR 9.06% to reach USD 9.33 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
IVD & LDT For Autoimmune Diseases Market by Technology (Clinical Chemistry, Coagulation, Hematology), Application (Addison’s Disease, Alopecia Areata, Ankylosing Spondylitis) - Global Forecast 2024-2030
... at USD 17.27 billion in 2023 and expected to reach USD 18.30 billion in 2024, at a CAGR 5.22% to reach USD 24.68 billion by 2030. Global IVD & LDT For Autoimmune Diseases Market FPNV ... Read More
-
Systemic Lupus Erythematosus Market by Drug Type (Antimalarial Drugs, B-Cell Modulators, Biologics), Mode of Delivery (Intravenous, Oral, Subcutaneous) - Global Forecast 2024-2030
... 2023 and expected to reach USD 2.24 billion in 2024, at a CAGR 10.54% to reach USD 4.12 billion by 2030. Global Systemic Lupus Erythematosus Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More